Phase I Study of QLS1103 in Subjects With Advanced Solid Tumors

NCT05884801 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

148

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: QLS1103

Sponsor

Qilu Pharmaceutical Co., Ltd.